Literature DB >> 30731186

Using the Proton Energy Spectrum and Microdosimetry to Model Proton Relative Biological Effectiveness.

Mark Newpower1, Darshana Patel2, Lawrence Bronk3, Fada Guan2, Pankaj Chaudhary4, Stephen J McMahon4, Kevin M Prise4, Giuseppe Schettino5, David R Grosshans6, Radhe Mohan2.   

Abstract

PURPOSE: We introduce a methodology to calculate the microdosimetric quantity dose-mean lineal energy for input into the microdosimetric kinetic model (MKM) to model the relative biological effectiveness (RBE) of proton irradiation experiments. METHODS AND MATERIALS: The data from 7 individual proton RBE experiments were included in this study. In each experiment, the RBE at several points along the Bragg curve was measured. Monte Carlo simulations to calculate the lineal energy probability density function of 172 different proton energies were carried out with use of Geant4 DNA. We calculated the fluence-weighted lineal energy probability density function (fw(y)), based on the proton energy spectra calculated through Monte Carlo at each experimental depth, calculated the dose-mean lineal energy yD¯ for input into the MKM, and then computed the RBE. The radius of the domain (rd) was varied to reach the best agreement between the MKM-predicted RBE and experimental RBE. A generic RBE model as a function of dose-averaged linear energy transfer (LETD) with 1 fitting parameter was presented and fit to the experimental RBE data as well to facilitate a comparison to the MKM.
RESULTS: Both the MKM and LETD-based models modeled the RBE from experiments well. Values for rd were similar to those of other cell lines under proton irradiation that were modeled with the MKM. Analysis of the performance of each model revealed that neither model was clearly superior to the other.
CONCLUSIONS: Our 3 key accomplishments include the following: (1) We developed a method that uses the proton energy spectra and lineal energy distributions of those protons to calculate dose-mean lineal energy. (2) We demonstrated that our application of the MKM provides theoretical validation of proton irradiation experiments that show that RBE is significantly greater than 1.1. (3) We showed that there is no clear evidence that the MKM is better than LETD-based RBE models.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30731186      PMCID: PMC6499683          DOI: 10.1016/j.ijrobp.2019.01.094

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  27 in total

1.  Comparison of GEANT4 very low energy cross section models with experimental data in water.

Authors:  S Incerti; A Ivanchenko; M Karamitros; A Mantero; P Moretto; H N Tran; B Mascialino; C Champion; V N Ivanchenko; M A Bernal; Z Francis; C Villagrasa; G Baldacchin; P Guèye; R Capra; P Nieminen; C Zacharatou
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

2.  The incorporation of the concept of minimum RBE (RbEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatments.

Authors:  Alejandro Carabe-Fernandez; Roger G Dale; Bleddyn Jones
Journal:  Int J Radiat Biol       Date:  2007-01       Impact factor: 2.694

Review 3.  In vitro RBE-LET dependence for multiple particle types.

Authors:  Brita Singers Sørensen; Jens Overgaard; Niels Bassler
Journal:  Acta Oncol       Date:  2011-08       Impact factor: 4.089

4.  Empirical model estimation of relative biological effectiveness for proton beam therapy.

Authors:  Y Chen; S Ahmad
Journal:  Radiat Prot Dosimetry       Date:  2011-05-18       Impact factor: 0.972

5.  Lineal energy and radiation quality in radiation therapy: model calculations and comparison with experiment.

Authors:  L Lindborg; M Hultqvist; Å Carlsson Tedgren; H Nikjoo
Journal:  Phys Med Biol       Date:  2013-04-18       Impact factor: 3.609

6.  Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.

Authors:  Christopher R Peeler; Dragan Mirkovic; Uwe Titt; Pierre Blanchard; Jillian R Gunther; Anita Mahajan; Radhe Mohan; David R Grosshans
Journal:  Radiother Oncol       Date:  2016-11-16       Impact factor: 6.280

7.  Relative biological effectiveness (RBE) values for proton beam therapy.

Authors:  Harald Paganetti; Andrzej Niemierko; Marek Ancukiewicz; Leo E Gerweck; Michael Goitein; Jay S Loeffler; Herman D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-06-01       Impact factor: 7.038

8.  Physical parameter optimization scheme for radiobiological studies of charged particle therapy.

Authors:  Changran Geng; Drake Gates; Lawrence Bronk; Duo Ma; Fada Guan
Journal:  Phys Med       Date:  2018-06-14       Impact factor: 2.685

9.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

10.  RBE Model-Based Biological Dose Optimization for Proton Radiobiology Studies.

Authors:  Fada Guan; Changran Geng; Duo Ma; Lawrence Bronk; Matthew Kerr; Yuting Li; Drake Gates; Benjamin Kroger; Narayan Sahoo; Uwe Titt; David Grosshans; Radhe Mohan
Journal:  Int J Part Ther       Date:  2018-09-21
View more
  2 in total

1.  Experimental validation of an analytical microdosimetric model based on Geant4-DNA simulations by using a silicon-based microdosimeter.

Authors:  A Bertolet; V Grilj; C Guardiola; A D Harken; M A Cortés-Giraldo; A Baratto-Roldán; A Carabe
Journal:  Radiat Phys Chem Oxf Engl 1993       Date:  2020-06-17       Impact factor: 2.858

2.  The relation between microdosimetry and induction of direct damage to DNA by alpha particles.

Authors:  Alejandro Bertolet; José Ramos-Méndez; Harald Paganetti; Jan Schuemann
Journal:  Phys Med Biol       Date:  2021-07-30       Impact factor: 4.174

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.